Cadient campaigns take home awards for Best New Product Introduction and
Best Interactive Consumer Campaign
WEST CONSHOHOCKEN, Pa., May 6 /PRNewswire/ -- Cadient Group, the premier strategic interactive marketing agency serving the healthcare industry, announced today it received two silver awards at the 2008 Pharmaceutical Advertising and Marketing Excellence Awards (PhAME) ceremony on Thursday, May 1, 2008. Cadient Group campaigns were honored in the categories of Best New Product Introduction and Best Interactive Consumer Campaign. This announcement follows quickly on the heels of Cadient Group's multiple award recognitions at the 2008 DTC National Advertising Awards.
"Cadient Group is committed to ensuring our clients' unique campaigns are appropriately aligned with relevant innovations to create meaningful experiences and deliver measurable results," said Stephen Wray, president and CEO, Cadient Group. "We're honored to have these campaigns recognized at this year's PhAME Awards, and feel they demonstrate the best-in-class digital design and user experience that results from the types of collaborative partnerships Cadient Group has established with leading pharmaceutical marketers."
Cadient Group received the following awards at this year's 2008 PhAME
Awards:
-- Silver Award -- Best New Product Introduction
Cadient Group was recognized with the silver award in the Best New
Product Introduction category for its work on Shire US, Inc.'s Vyvanse
(lisdexamfetamine dimesylate) launch campaign
-- Silver Award -- Best Interactive Consumer Campaign
Cadient Group and Novartis Vaccines' FluFlix Vaccine Awareness Contest
received the silver award in the Best Interactive Consumer Campaign
category
The Pharmaceutical Advertising and Marketing Excellence (PhAME) Awards
recognize creative excellence, results that contribute to the public
health, a
'/>"/>
| SOURCE Cadient Group Copyright©2008 PR Newswire. All rights reserved |